Naz Marzieh Saei Ghare, Tehrani Fahimeh Ramezani, Majd Hamid Alavi, Ahmadi Fazlollah, Ozgoli Giti, Fakari Farzaneh Rashidi, Ghasemi Vida
Student Research Committee, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences Tehran Iran.
Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran.
Int J Reprod Biomed. 2019 Sep 3;17(8):533-542. doi: 10.18502/ijrm.v17i8.4818. eCollection 2019 Aug.
Polycystic ovarian syndrome is an endocrine disorder with many complications. This syndrome is a growing concern among adolescents around the world, with varying reports of its prevalence in different parts of the world.
This study aimed to determine the prevalence of polycystic ovary syndrome in adolescents by a systematic review and meta-analysis.
In this study, a search for published articles with an English language limitation and without a time limit was done in different databases (Scopus, PubMed, and Web of Science, Emabse and Cochrane) in January 2019. The 12 studies that met the criteria for entering a qualitative assessment scale of 5 and higher were subjected to systematic review and meta-analysis. Egger and Begg's tests were used to check the publication bias. Data were analyzed with STATA software, version 11.1.
Twelve studies were included for meta-analysis. The total number of participants in the study was 149,477. The average quality score of all studies was 8.67 (range: 5-10). The prevalence of polycystic ovarian syndrome in adolescents based on the Rotterdam criteria was 11.04% (95% CI: 6.84-16.09%), based on the National Institute of Health criteria, it was 3.39% (95% CI: 0.28-9.54%), and based on Androgen Excess and Polycystic Ovary Syndrome Society, it was 8.03% (95% CI: 6.24-10.01%).
The result of this study showed that there is a variation in the prevalence of PCOS in adolescents based on different criteria; we suggest more community-based studies among adolescences in different parts of the world.
多囊卵巢综合征是一种伴有多种并发症的内分泌紊乱疾病。该综合征在全球青少年中日益受到关注,世界各地关于其患病率的报道各不相同。
本研究旨在通过系统评价和荟萃分析确定青少年多囊卵巢综合征的患病率。
本研究于2019年1月在不同数据库(Scopus、PubMed、Web of Science、Emabse和Cochrane)中检索了有英文语言限制且无时间限制的已发表文章。对符合进入5分及以上定性评估量表标准的12项研究进行系统评价和荟萃分析。采用Egger检验和Begg检验检查发表偏倚。使用STATA 11.1软件进行数据分析。
纳入12项研究进行荟萃分析。研究参与者总数为149477人。所有研究的平均质量评分为8.67(范围:5 - 10)。根据鹿特丹标准,青少年多囊卵巢综合征的患病率为11.04%(95%置信区间:6.84 - 16.09%),根据美国国立卫生研究院标准为3.39%(95%置信区间:0.28 - 9.54%),根据雄激素过多和多囊卵巢综合征学会标准为8.03%(95%置信区间:6.24 - 10.01%)。
本研究结果表明,基于不同标准,青少年多囊卵巢综合征的患病率存在差异;我们建议在世界不同地区的青少年中开展更多基于社区的研究。